DYADIC INTERNATIONAL INC Deferred Tax Assets, Gross
DYADIC INTERNATIONAL INC (DYAI) had Deferred Tax Assets, Gross of $15.46 million as of 2022-12-31, per its 10-K filed 2023-03-29.
Discontinued › Notes › Components of Deferred Tax Assets and Liabilities › Deferred Tax Assets, Gross
us-gaap:DeferredTaxAssetsGross · last filed 2023-03-29
- 2022-12-31: Deferred Tax Assets, Gross $15.46M.
- 2021-12-31: Deferred Tax Assets, Gross $13.04M.
- 2020-12-31: Deferred Tax Assets, Gross $9.36M.
- 2019-12-31: Deferred Tax Assets, Gross $7.15M.
| Period end | Deferred Tax Assets, Gross |
|---|---|
| 2022-12-31 | $15.46M 10-K · filed 2023-03-29 |
| 2021-12-31 | $13.04M 10-K · filed 2023-03-29 |
| 2020-12-31 | $9.36M 10-K · filed 2022-03-29 |
| 2019-12-31 | $7.15M 10-K · filed 2021-03-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BioCardia, Inc. (BCDA) | United States | $0.016B | |
| Passage BIO, Inc. (PASG) | United States | $0.015B | -0.43 |
| Pluri Inc. (PLUR) | $0.014B | ||
| INTENSITY THERAPEUTICS, INC. (INTS) | United States | $0.013B | -1.08 |
| BRAINSTORM CELL THERAPEUTICS INC. (BCLI) | United States | $0.013B | -1.05 |
| Jasper Therapeutics, Inc. (JSPR) | United States | $0.020B | -0.37 |
| IN8BIO, INC. (INAB) | United States | $0.012B | -0.76 |
| Estrella Immunopharma, Inc. (ESLA) | United States | $0.020B | |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |